Guided Therapeutics Inc (GTHP): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$2.31M
As of 2022-12-31
+37.0%
3-year compound annual growth
n/m
5-year compound annual growth
+8.3%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $2.31M | +259.7% | 2023-03-30, Balance as of period end |
| 2021-12-31 | $643.0K | +253.3% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $182.0K | -79.8% | 2022-03-30, Balance as of period end |
| 2019-12-31 | $899.0K | n/a | 2021-04-07, Balance as of period end |
| 2018-12-31 | $0 | -100.0% | 2020-04-20, Balance as of period end |
| 2017-12-31 | $1.0K | -92.9% | 2019-05-08, Balance as of period end |
| 2016-12-31 | $14.0K | -60.0% | 2018-04-20, Balance as of period end |
| 2015-12-31 | $35.0K | -78.4% | 2017-03-22, Balance as of period end |
| 2014-12-31 | $162.0K | -73.6% | 2016-03-15, Balance as of period end |
| 2013-12-31 | $613.0K | -41.3% | 2015-03-25, Balance as of period end |
| 2012-12-31 | $1.04M | -52.5% | 2014-03-26, Balance as of period end |
| 2011-12-31 | $2.20M | -32.7% | 2013-03-27, Balance as of period end |
| 2010-12-31 | $3.27M | n/a | 2012-03-28, Balance as of period end |